Eventide Asset Management logo

Eventide Asset Management

Crunchbase
Pitchbook
Crunchbase

Deals on record

5

Common Fundraising Type

Series B

Beta Bionics logo
Beta Bionics

Medical Technology

Wellington Management logo
RTW Investments logo
Soleus Capital logo
Sands Capital logo
Perceptive Advisors logo
Omega Funds logo
Marshall Wace logo
Eventide Asset Management logo

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.

Series E
$60M
11/15/2024
Article
PreciseDx logo
PreciseDx

AI-driven

Quest Diagnostics logo
Labcorp logo
GenHenn Capital Venture logo
Eventide Asset Management logo

PreciseDx is a company that uses AI-driven technology to provide detailed diagnostics and risk assessments for oncology, particularly focusing on breast cancer.

Series B
$20.7M
08/21/2024
Article
Sudo Biosciences logo
Sudo Biosciences

Biopharmaceuticals

Enavate Sciences logo
TPG logo
Sanofi Ventures logo
Surveyor Capital logo
Monograph Capital logo
Frazier Life Sciences logo
Velosity Capital logo
Eventide Asset Management logo

Sudo Biosciences is a biopharmaceutical company developing TYK2 inhibitor candidates for the treatment of multiple sclerosis, neurodegenerative, and immune-mediated dermatologic diseases.

Series B
$116M
12/20/2023
Article
Avalyn Pharma logo
Avalyn Pharma

Biopharmaceutical

Perceptive Xontogeny Venture Funds logo
Wellington Management logo
Vida Ventures logo
T. Rowe Price Associates logo
SR One logo
Rock Springs Capital logo
RiverVest Venture Partners logo
Pivotal bioVenture Partners logo

Avalyn Pharma is a biopharmaceutical company that develops inhalation therapies for rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases, with a focus on creating new inhaled formulations of approved medicines.

Series C
$175M
09/27/2023
Article
Beta Bionics logo
Beta Bionics

Medical Technology

Soleus Capital logo
Sands Capital logo
RTW Investments logo
Pura Vida Investments logo
Perceptive Advisors logo
Omega Funds logo
Marshall Wace logo
Farallon Capital logo

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.

Series D
$100M
09/01/2023
Article